ÂÜÀòÂÒÂ×

Karoly Nikolich is an accomplished executive with extensive experience in the biopharmaceutical and academic sectors. Currently serving as an Executive Strategic Advisor at Grifols and a Board Member for Engrail Therapeutics and Hummingbird Diagnostics, Karoly also provides strategic advice as a Strategic Advisor for Pivotal bioVenture Partners and holds an Adjunct Professor position in Psychiatry at Stanford University Medical School. With a strong entrepreneurial background, Karoly co-founded Alkahest, Inc. and served as its Chairman and CEO, where a focus was placed on innovative plasma proteomics. Additional leadership roles include Chairman of the Scientific Advisory Board at Neuropore Therapies and a Board member at Chase Pharmaceuticals. Karoly holds a PhD in Biochemistry from Eötvös Loránd University and furthered education at Tulane University and the University of California, San Francisco - School of Medicine.